iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 drug iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Shortages improve for Lilly's GLP-1 weight loss drugs, bumping sales forecast by $3bn-bsmoothhr The FDA approved Wegovy HD

10.1016/j.juro.2013.08.110 J Urol

The product should be stored out of the reach of small children

This formulation offers a more convenient and highly efficient reliable option that could be a potential alternative to commercial products for mixed drinking-water medication of livestock and poultry, particularly under high-density, centralized management conditions

Discussion With the popularity of GLP-1 RA medications and challenges in access and insurance coverage, we will continue to monitor prescribing and dispensing trends over time

14 (4), e1007304

However, FDA inspections have identified quality control concerns, and the parent company has a documented history of regulatory issues